A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2013 by PCI Biotech AS
Sponsor:
Information provided by (Responsible Party):
PCI Biotech AS
ClinicalTrials.gov Identifier:
NCT01900158
First received: May 15, 2013
Last updated: July 22, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2015
  Estimated Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)